PhaseRX sells to Riovant Sciences for $800000 two months after decla...
02/06/18
![]()
PhaseRX sells to Riovant Sciences for $800000 two months after declaring bankruptcy
GeekWire
Riovant will repay millions in debt that PhaseRX owed to Hercules Capital at the time of its bankruptcy and will retain the right to continue developing the company's leading drug candidate, according to court filings. Neither company immediately ...
[more]
GeekWire
Riovant will repay millions in debt that PhaseRX owed to Hercules Capital at the time of its bankruptcy and will retain the right to continue developing the company's leading drug candidate, according to court filings. Neither company immediately ...